Rare diseases impact populations across the globe, but despite that wide swath of known patients, the majority of clinical work is conducted in the United States and the European Union. There is a lack of diversity within the patient populations being tested for potential therapies, including cutting-edge gene therapies.
Breaking Barriers in Rare Disease Research and Drug Development – Insights from IndoUSrare’s Rare Disease Day Event
